Welcome to our dedicated page for Aemetis SEC filings (Ticker: AMTX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Aemetis, Inc. (NASDAQ: AMTX) SEC filings page provides access to the company’s official disclosures as a Delaware corporation listed on the NASDAQ Global Market. Through forms such as 10-K, 10-Q, and 8-K, Aemetis reports details about its renewable natural gas, renewable fuel, and biochemicals operations in California and India, along with its financial condition and material agreements.
Current reports on Form 8-K offer insight into key events, including quarterly earnings releases and significant financing arrangements. For example, Aemetis has filed 8-Ks to furnish press releases covering results for periods ended June 30 and September 30, 2025, and to describe amendments to the Series A Preferred Unit Purchase Agreement for its Aemetis Biogas LLC subsidiary. These filings outline redemption obligations, potential credit agreements, and security interests related to the dairy RNG platform.
Investors can use annual reports on Form 10-K and quarterly reports on Form 10-Q to review segment information for California ethanol, dairy renewable natural gas, and India biodiesel operations, as well as risk factors tied to commodity prices, regulatory programs such as LCFS and federal tax credits, and project development. These filings also discuss accumulated deficits, debt levels, and capital investments in projects like the Mechanical Vapor Recompression system and dairy digesters.
In addition, forms related to securities and capital structure provide information on Aemetis’ common stock registered on the NASDAQ Global Market under the symbol AMTX, and on obligations of subsidiaries and guarantors. Where available, Form 4 and related ownership filings can be used to monitor insider transactions by officers, directors, or significant shareholders.
On Stock Titan, AI-powered tools can help summarize lengthy Aemetis filings, highlight key terms in credit agreements, and explain complex tables in earnings releases. Real-time updates from EDGAR ensure that new 8-Ks, 10-Qs, and 10-Ks for AMTX are quickly reflected, allowing users to review how regulatory disclosures align with the company’s renewable fuels and RNG strategy.
Barton Francis P, identified as a director of Aemetis, Inc. (AMTX), reported multiple open-market sales of the issuer's common stock on 08/14/2025. Four sale transactions at a price of $2.5335 per share disposed of 1,300, 12,152, 5,000 and 8,000 shares, totaling 26,452 shares sold. The filings show the reporting person’s beneficial ownership decreased from 233,670 shares pre-sale (as reflected after the first line) to 208,518 shares following the last reported transaction. The Form 4 is signed by an attorney-in-fact on behalf of the reporting person.
A Form 144 notice shows a proposed sale of 26,452 shares of common stock of the issuer via Raymond James & Associates on 08/14/2025, with an aggregate market value of $66,923.56. The shares reported for sale were granted as restricted stock units (RSUs) by the issuer on 01/07/2021 (1,300 shares), 04/08/2021 (12,152 shares), 11/18/2021 (5,000 shares), and 08/18/2022 (8,000 shares). The filer reports no securities sold during the past 3 months and indicates payment for these proposed sales will be cash. The filing includes the standard representation that the seller does not possess undisclosed material information about the issuer.